Renhe Pharmacy Co.,Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Renhe Pharmaceutical Co., Ltd. is a listed company listed on the Shenzhen Stock Exchange with the stock code 000650. Its predecessor was Jiujiang Chemical Fiber Co., Ltd. It was approved by the People's Government of Jiangxi Province in 1996 and officially listed on the Shenzhen Stock Exchange on November 18, 1996 with the approval of China Securities Regulatory Commission's Zheng Jian Fa Zi (1996) No. 318 document. In 2006, the company implemented a major asset restructuring, divesting its existing chemical fiber related assets and injecting pharmaceutical assets. Through multiple equity placements, conversion, and targeted issuance, the company has now become a subsidiary of Jiangxi Renhe Pharmaceutical Co., Ltd., Jiangxi Renhe Zhongfang Pharmaceutical Co., Ltd., Jiangxi Renhe Pharmaceutical Capital Co., Ltd., Jiangxi Heli Pharmaceutical Co., Ltd., Jiangxi Kangmei Pharmaceutical Health Products Co., Ltd Jiangxi Yaodu Renhe Pharmaceutical Co., Ltd., Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd., Jiangxi Shinliang Pharmaceutical Co., Ltd., Jiangxi Ji'an Sanli Pharmaceutical Co., Ltd., Jiangxi Renhe Pharmaceutical Plastic Products Co., Ltd., Jiangxi Pharmaceutical Co., Ltd., Jiangxi Yaodu Zhangshu Pharmaceutical Co., Ltd. and other modern pharmaceutical production and operation enterprises. |
| Headquarter | Yichun |
| Establish Date | 12/4/1996 |
| Listed Code | 000650.SZ |
| Listed Date | 12/10/1996 |
| Chairman | Yang Xiao. |
| CEO | Huang Wujun. |
| Website | www.renheyaoye.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
